Effectiveness and Safety of Fluticasone Propionate in Adolescents and Adults Who Have Asthma

Study Title
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Teva Identifier
FpS-AS-201 | 2010-023600-27
ClinicalTrials.gov Identifier
NCT01479621
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Fp MDPI | Drug: Flovent Diskus | Drug: albuterol/salbutamol | Drug: Placebo MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Child, Adult, Older Adult
Age Range
12 Years and older
Trial Duration
01/01/2012 - 07/01/2013
Phase
Phase 2

Study Type

Interventional